BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 29, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Merck & Co. discloses new FABP inhibitors
June 9, 2010
Preliminary phase III data reported on oral insulin spray
June 8, 2010
New FABP inhibitors presented
June 8, 2010
FDA advisory committee review of lorcaserin set for September
June 7, 2010
PregLem reports phase III data on Esmya in uterine fibroids
June 4, 2010
StronBone bone graft substitute shows efficacy in vivo
June 4, 2010
Banyu and Merck & Co. disclose new DGAT-1 inhibitors
June 4, 2010
FDA accepts Orexigen's Contrave NDA in obesity for filing
June 3, 2010
FDA grants orphan drug status to THPB in Niemann Pick type C disease
June 3, 2010
FDA approves Prolia therapy for postmenopausal women with osteoporosis
June 3, 2010
Previous
1
2
…
695
696
697
698
699
700
701
702
703
…
1801
1802
Next
RSS